68 related articles for article (PubMed ID: 2440966)
1. [Preparation and characterization of a monoclonal antibody reactive with human ovarian serous cystadenocarcinoma].
Ookura N
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):47-58. PubMed ID: 2440966
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
3. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
[TBL] [Abstract][Full Text] [Related]
5. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
[No Abstract] [Full Text] [Related]
7. Immuno-histological characterization of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
Neungton N; Moongkarndi P; Laohathai K; Neungton S; Juntrachotiwit P
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):129-34. PubMed ID: 1284830
[TBL] [Abstract][Full Text] [Related]
8. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
[TBL] [Abstract][Full Text] [Related]
9. Morphological and immunological heterogeneity of human ovarian neoplasms.
Harłozińska A; Rabczyński J; Bar JK; Richter R
Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
[TBL] [Abstract][Full Text] [Related]
10. [Polysaccharide complex of human ovarian cancer studied by the microprecipitation reaction].
Gorodilova VV; Ul'chenko VM
Vopr Onkol; 1980; 26(11):62-5. PubMed ID: 7456427
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas.
Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY
Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724
[TBL] [Abstract][Full Text] [Related]
12. [Preparation and characteristics of human monoclonal antibody HMD4 against ovarian epithelial carcinoma].
Cui H
Zhonghua Yi Xue Za Zhi; 1989 Jan; 69(1):46. PubMed ID: 2758347
[No Abstract] [Full Text] [Related]
13. Characterization of the antigen recognized by monoclonal antibody 1D3.
Gangopadhyay A; Chatterjee SK; Bhattacharya M; Barlow JJ
Cancer Biochem Biophys; 1988 Nov; 10(2):107-15. PubMed ID: 3252956
[TBL] [Abstract][Full Text] [Related]
14. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
Qian HN; Lu WY
Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388
[TBL] [Abstract][Full Text] [Related]
16. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies.
Dahl MV; Ristow S
Arch Dermatol; 1978 Jun; 114(6):903-5. PubMed ID: 78684
[TBL] [Abstract][Full Text] [Related]
18. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
Shi ZL
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
Harlozinska A; Bar JK; Richter R; Cislo M
Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
[TBL] [Abstract][Full Text] [Related]
20. [The construction and expression of 6B11scFv anti-idiotypic antibody and human granulocyte-macrophage-colony stimulating factor in Escherichia coli].
Yang F; Qian H; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):417-9. PubMed ID: 11360654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
